Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 181 | 173 | 220 | 156 | 164 |
| Accounts receivable | 38 | 167 | -397 | 44 | -6 |
| Other Working Capital | 632 | -446 | -135 | 10 | -176 |
| Other Operating Activity | -2,045 | -1,739 | -1,392 | -1,688 | -1,350 |
| Operating Cash Flow | $-1,194 | $-1,845 | $-1,704 | $-1,478 | $-1,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -175 | -25 | -57 | -22 |
| Other Investing Activity | 14 | 29 | 17 | 14 | 29 |
| Investing Cash Flow | $-13 | $-145 | $-8 | $-42 | $7 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,000 | 0 | N/A |
| Debt Repayment | -11 | -44 | -84 | -9 | -9 |
| Other Financing Activity | 106 | -22 | 4,302 | 0 | 0 |
| Financing Cash Flow | $95 | $-66 | $5,218 | $-9 | $-9 |
| Exchange Rate Effect | -14 | 21 | 16 | -23 | 26 |
| Beginning Cash Position | 2,163 | 4,197 | 675 | 2,228 | 3,572 |
| End Cash Position | 1,037 | 2,163 | 4,197 | 675 | 2,228 |
| Net Cash Flow | $-1,111 | $-2,056 | $3,506 | $-1,530 | $-1,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,194 | -1,845 | -1,704 | -1,478 | -1,368 |
| Capital Expenditure | -27 | -175 | -25 | -57 | -22 |
| Free Cash Flow | -1,221 | -2,020 | -1,729 | -1,535 | -1,390 |